DexCom Inc. Company Profile
NASDAQ: DXCMHealth CareMedical/Dental InstrumentsUSD
Market open · Delayed 15 min · as of Oct 9, 10:29 AM ET
DexCom at a glance
DexCom Inc. (NASDAQ: DXCM) is a Medical/Dental Instruments company in the Health Care sector headquartered in San Diego, CA. DexCom is led by Mr. Jacob Steven Leach and employs about 11,000 people. The company's shares have traded publicly since 2005.
At a market capitalization of $31.81 billion, it is considered a large-cap company. DXCM is a member of the SP500, NDX. Its SEC Central Index Key (CIK) is 0001093557, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does DexCom do?
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin; Dexcom Share, a remote monitoring system; and Dexcom Follow application. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
Business description based on the company's public filings.
Company information
- Legal name
- DexCom Inc.
- Ticker
- NASDAQ: DXCM
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Jacob Steven Leach
- Employees
- 11,000
- Headquarters
- 6340 Sequence Drive, San Diego, CA, United States
- Phone
- 858 200 0200
- Website
- dexcom.com
- IPO year
- 2005
- Market cap
- $31.81B
- SEC CIK
- 0001093557
- Latest annual report
- 10-K · Feb 12, 2026
Index membership
Companies similar to DexCom
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| RMDResMed Inc. | 229.22 | +1.10% | $32.24B | vs DXCM |
| WSTWest Pharmaceutical Services Inc. | 368.52 | +1.45% | $25.94B | vs DXCM |
| MDLNMedline Inc. Class A | 35.68 | -0.17% | $48.01B | vs DXCM |
| SOLVSolventum Corporation | 87.83 | +1.64% | $14.95B | vs DXCM |
| BDXBecton Dickinson and Company | 183.27 | +0.28% | $49.92B | vs DXCM |
| PENPenumbra Inc. | 318.49 | +0.31% | $12.55B | vs DXCM |
| BAXBaxter International Inc. | 24.26 | +1.49% | $12.54B | vs DXCM |
| GMEDGlobus Medical Inc. Class A | 75.12 | +2.43% | $10.09B | vs DXCM |